Displaying drugs 7701 - 7725 of 9386 in total
Flovagatran
Investigational
PPI-1019
Apan (PPI-1019) is developed by Praecis Pharmaceuticals to treat Alzheimer's Disease.
Investigational
Rebimastat
Investigational
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide
Experimental
Eribaxaban
Experimental
D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide
Experimental
GW-813893
Experimental
ISOTHIAZOLIDINONE ANALOG
Experimental
Danusertib
Danusertib has been used in trials studying the treatment of Leukemia.
Investigational
Matched Categories: … Protein Kinase Inhibitors …
LY-3039478
LY3039478 has been used in trials studying the treatment and basic science of LYMPHOMA, Neoplasms, Solid Tumor, COLON CANCER, and BREAST CANCER, among others.
Investigational
Volasertib
Volasertib has been used in trials studying the treatment of Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and Leukemia, Monocytic, Acute, among others.
Investigational
Soblidotin
Soblidotin has been used in trials studying the treatment of Sarcoma, Lung Cancer, and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
HKI-357
Hki 357 is under investigation in clinical trial NCT00550381 (Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects).
Investigational
Clometocillin
Experimental
Sulbenicillin
Experimental
Pyrotinib
Pyrotinib is under investigation in clinical trial NCT03756064 (Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer).
Investigational
19-Nor-5-androstenedione
19-Nor-5-andorstenedione is a prohormone which has the potential to affect bodily levels of testosterone once metabolized in vivo. It is regulated in the United States as a schedule III controlled substance, and prohibited by the World Anti-Doping Agency for use in competitive sports.
Experimental
Illicit
Displaying drugs 7701 - 7725 of 9386 in total